Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 5, 1997, Pages 1173-1182

  Roberts, Stephen A ^a,b   Hendry, Jolyon H ^a   Slevin, Nicholas J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Larynx cancer; Linear quadratic models; Time factor

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; LARYNX CANCER; MATHEMATICAL MODEL; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TIME;

CARCINOMA; HUMANS; LARYNGEAL NEOPLASMS; LINEAR MODELS; MODELS, BIOLOGICAL; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 0030658008     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00492-6     Document Type: Article

References (34)

1. Bentzen, S. M. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. Int. J. Radiat. Biol. 61:417-423; 1992.
2. Bentzen, S. M. Radiobiological considerations in the design of clinical trials. Radiother. Oncol. 32:1-11; 1994.
3. Bentzen, S. M.; Thames, H. D. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother. Oncol. 22:161-166; 1991.
4. Cummings, B. J.; Keane, T. J.; Pintile, M.; O'Sulivan, B.; Payne, D.; Warde, P.; McLean, M.; Waldron, J.; Liu, F. F.; Gullane, P. A prospective randomised trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx. (Abstr.) Radiother. Oncol. 40:830; 1996.
5. Harwood, A. R.; De Boer, G. Prognostic factors in T2 glottic cancer. Cancer 45:991-995; 1980.
6. Hendry, J. H. Treatment acceleration in radiotherapy: The relative time factors and dose-response slopes for tumors and normal tissues. Radiother. Oncol. 25:308-312; 1992.
7. Hendry, J. H.; Roberts, S. A.; Slevin, N. J.; Keane, T. J.; Barton, M. B.; Agren-Cronqvist, A. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centres in Manchester, UK and Toronto, Canada. Radiother. Oncol. 31:14-22; 1994.
8. Horiot, J. C.; Bontemps, P.; Le Fur, R.; van de Bogaert, W.; Bolla, M.; van Weijngaert, D.; Bernier, J.; Lusinchi, A.; Stuschke, M.; Lopez Torrecilla, D.; Collette, L.; Pierart, M. An overview of the EORTC accelerated and hyperfractionated radiotherapy trials in head and neck cancers. (Abstr.) Radiother. Oncol. 40:830; 1996.
9. Howell-Burke, D.; Peters, L. J.; Goepfert, H.; Oswald, M. J. Recurrence, salvage and survival after definitive radiotherapy. Arch. Otolaryngol. Head Neck Surg. 116:830-835; 1990.
10. MacDougall, R. H.; Orr, J. A.; Kerr, G. R.; Duncan, W. Fast neutron treatment for squamous cell carcinoma of the head and neck: Final report of Edinburgh randomised trial. Br. Med. J. 301:1241-1242; 1990.
11. Maciejewski, B.; Taylor, J. M. G.; Withers, H. R. α/β value and the importance of size of dose per fraction for late complications in the supraglottic larynx. Radiother. Oncol. 7:323-326; 1986.
12. Maciejewski, B.; Skladowski, K.; Pilecki, B.; Taylor, J. M. G.; Withers, H. R.; Miszcztk, L.; Zajusz, A.; Suwinski, R. Randomised clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother. Oncol. 40:137-145; 1996.
13. Maciejewski, B.; Withers, H. R.; Taylor, J. M. G.; Hliniak, A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int. J. Radiat. Biol. Phys. 18:101-111; 1990.
14. Mendenhall, W. M.; Parsons, J. T.; Millon, R. R.; Fletcher, G. H. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: Relationship of dose-fractionation factors to local control and complications. Int. J. Radiat. Oncol. Phys. 15:1267-1273; 1988.
15. Overgaard, J.; Sand Hansen, H.; Sapru, W.; Overgaard, M.; Grau, C.; Jorgensen, K.; Bastholt, L.; Hansen, O.; Specht, L.; Berthelsen, A.; Pedersen, M. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomised multicenter study of 5 versus 6 fractions per week-preliminary report from the DAHANCA 6 and 7 trial. (Abstr.) Radiother. Oncol. 40:S31; 1996.
16. Rezvani, M.; Alcock, C. J.; Fowler, J. F.; Haybittle, J. L.; Hopewell, J. W.; Wiernik, G. Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the larygo-pharynx by radiotherapy. Br. J. Radiol. 64:1122-1133; 1991.
17. Roberts, S. A.; Hendry, J. H.; Brewster, A. E.; Slevin, N. J. The influence of radiotherapy treatment time on the control of laryngeal cancer: A direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor. Br. J. Radiol. 67:790-794; 1994.
18. Roberts, S. A.; Hendry, J. H. The delay before onset of accelerated tumor cell repopulation: A direct maximum-likelihood analysis of a collection of worldwide tumor-control data. Radiother. Oncol. 29:69-74; 1993.
19. Robertson, A. G.; Robertson, C.; Boyle, P.; Symonds, R. P.; Wheldon, T. E. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur. J. Cancer 29A:501-510; 1993.
20. Robertson, C.; Robertson, A. G.; Hendry, J. H.; Roberts, S. A.; Slevin, N. J.; Duncan, W. B.; MacDougall, H.; Kerr, G.; O'Sullivan, B.; Keane, T. J. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Submitted to Int. J. Radiat. Oncol. Biol. Physics.
21. Saunders, M. I.; Dische, S.; Barrett, A.; Parmar, M. K. B.; Harvey, A.; Gibson, D. Randomised multicentre trials of CHART vs conventional therapy in head and neck and nonsmall-cell lung cancer: An interim report. Br. J. Cancer 73: 1455-1462; 1996.
22. Slevin, N. J.; Vasanthan, S.; Dougal, M. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of normal tissue morbidity following larynx radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 25:22-28; 1992.
23. Slevin, N. J.; Hendry, J. H.; Roberts, S. A.; Agren-Cronqvist, A. The effect of increasing treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother. Oncol. 24:215-220; 1992.
24. Thames, H. D.; Bentzen, S. M.; Turesson, I.; Overgaard M.; Van den Bogaert, W. Time-dose factors in radiotherapy: A review of the human data. Radiother. Oncol. 19:219-235; 1990.
25. Thames, H. D.; Bentzen, S. M. Time factor for tonsillar carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 33:755-758; 1995.
26. Tucker, S. L.; Taylor, J. M. G. Improved models of tumour cure. Int. J. Radiat. Biol. 70:539-553; 1996.
27. Tucker, S. L.; Thames, H. D.; Taylor, J. M. G. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat. Res. 124:273-282; 1990.
28. Wang, C. C. Factors influencing the success of radiation therapy for T2 and T3 glottic carcinomas. Am. J. Clin. Oncol. 9:517-520; 1986.
29. Wiernik, G.; Alcock, C. J.; Bates, T. D.; Brindle, J. M.; Fowler, J. F.; Gajek, W. R.; Goodman, S.; Haybittle, J. L.; Henk, J. M.; Hopewell, J. W.; Hunter, R. D.; Lindup, R.; Phillips, D. L.; Rezvani, M. Final report on the second British Institute of Radiology fractionation study: Short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br. J. Radiol. 64:232-241; 1991.
30. Wiernik, G.; Alcock, C. J.; Bates, T. D.; Berry, R. J.; Brindle, J. M.; Dalby, J. E.; Fowler, J. F.; Gajek, W. R.; Goodman, S.; Haybittle, J. L.; Henk, J. M.; Hopewell, J. W.; Lindup, R.; Phillips, D. L.; Pointon, R. S.; Rezvani, M.; Tobias, J. S. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of laryngo-pharynx. Br. J. Radiol. 63:169-180; 1990.
31. Withers, H. R.; Peters, L. J.; Taylor, J. M. G.; Owen, J. B.; Morrison, W. H.; Schultheiss, T. E.; Keane, T.; O'Sullivan, B.; van Dyk, J.; Gupta, N.; Wang, C. C.; Jones, C. U.; Doppke, K. P.; Myint, S.; Thompson, M.; Parsons, J. T.; Mendenhall, W. M.; Dische, S.; Aird, E. G. A.; Henk, M.; Bidmead, M. A. M.; Svoboda, V., Chon, Y.; Hanlon, A. L.; Peters, T. L.; Hanks, G. E. Local control of carcinoma of the tonsil: An analysis of patterns of fractionation in nine institutions. Int. J. Radiat. Oncol. Biol. Phys. 33:549-562; 1995.
32. Withers, H. R.; Peters, L. J.; Taylor, J. M. G.; Owen, J. B.; Morrison, W. H.; Schultheiss, T. E.; Keane, T.; O'Sullivan, B.; Vandyk, J.; Gupta, N.; Wang, C. C.; Jones, C. U.; Doppke, K. P.; Myint, S.; Thompson, M.; Parsons, J. T.; Mendenhall, W. M.; Dische, S.; Aird, E. G. A.; Henk, M.; Bidmead, M. A. M.; Svoboda, V.; Chon, Y.; Hanlon, A. L.; Peters, T. L.; Hanks, G. E. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study. Int. J. Radiat. Oncol. Biol. Phys. 33:563-568; 1995.
33. Withers, H. R.; Taylor, J. M. G.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.
34. Zagars, G. K.; Schultheiss, T. E.; Peters, L. J. Inter-tumor heterogeneity and radiation dose-control curves. Radiother. Oncol. 8:353-362; 1987.